##plugins.themes.academic_pro.article.main##

Abstract

Local anesthetics have an impressive history of efficacy and safety in medical and dental practice. Their use is not so regular, and the negative effects are so low, that providers can overlook a lot of their pharmacotherapeutic principles understandable. The purpose of this continuing education article is important for various local anesthesia formulas in current use. Local anesthetics inhibit nerve conduction by inhibiting the passage of sodium ions through channels or ionophores within neural membranes. Usually these channels are present at rest, during which access to sodium ions is prohibited. When the neuron is excited, the channel adopts an activated or open state, in which sodium ions spread to the cell and begin depolarization. After a sharp change in membrane voltage, the sodium channel adopts an inactive state, at which point the active transport mechanisms return sodium ions outward. After this repolarization, the canal receives a normal state of rest. Valuing these sodium channel States helps explain the privileged sensitivity of local anesthetics for different classes of neuronal fibers

Keywords

Local anesthetics Pharmacology Drug toxicity

##plugins.themes.academic_pro.article.details##

How to Cite
Abdumanobov Mashhurbek Mansur o’g’li. (2023). Local Anesthetics: Review of Pharmacological Considerations. Texas Journal of Medical Science, 27, 60–63. https://doi.org/10.62480/tjms.2023.vol27.pp60-63

References

  1. Berde CB, Strichartz GR. Local anesthetics. In: Miller RD, Eriksson LI, Fleisher LA, et al., editors. Miller's Anesthesia. 7th ed. Philadelphia, Pa: Elsevier, Churchill Livingstone; 2009.
  2. Katzung BG, White PF. Local anesthetics. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New York, NY: McGraw-Hill Companies Inc; 2009.
  3. Goodson JM, Moore PA. Life-threatening reactions after pedodontic sedation: an assessment of narcotic, local anesthetic and antiemetic drug interactions. J Am Dent Assoc. 1983;107:239–245.
  4. Scott DB, Jebson PJR, Braid DP, et al. Factors affecting plasma levels of lignocaine and prilocaine. Brit J Anaesth. 1972;44:1040–1049.
  5. Hersh EV, Giannakopoulos H, Levin LM, et al. The pharmacokinetics and cardiovascular effects of high-dose articaine with 1 ∶ 100,000 and 1 ∶ 200,000 epinephrine. J Am Dent Assoc. 2006;137:1562–1571.
  6. Benz EJ. Disorders of hemoglobin. In: Longo DL, Kasper DL, Jameson JL, et al., editors. Harrison's Principles of Internal Medicine. 18th ed. New York, NY: McGraw Hill; 2012.
  7. Schatz M. Adverse reactions to local anesthetics. Immunol Allergy Clin North Am. 1992;12:585–609.
  8. Gell PGH, Coombs RRA. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell PGH, Coombs RRA, Hachmann PJ, editors. Clinical Aspects of Immunology. 3rd ed. Oxford, England: Blackwell Scientific; 1975.
  9. Adkinson NF., Jr . Drug allergy. In: Adkinson NF Jr, Yunginger JW, Busse WW, et al., editors. Middleton's Allergy: Principles and Practice. 6th ed. Philadelphia, Pa: Mosby Inc; 2003.
  10. Gall H, Kaufmann R, Kalveram CM. Adverse reactions to local anesthetics: analysis of 197 cases. J Allergy Clin Immunol. 1996;97:933–937.
  11. Berkun Y, Ben-Zvi A, Levy Y, Galili D, Shalit M. Evaluation of adverse reactions to local anesthetics: experience with 236 patients. Ann Allergy Asthma Immunol. 2003;91:342–345.
  12. Speca SJ, Boynes SG, Cuddy MA. Allergic reactions to local anesthetic formulations. Dent Clin North Am. 2010;54:655–664.
  13. deShazo RD, Kemp SF. Allergic reactions to drugs and biologic agents. JAMA. 1997;278:1895–1906.
  14. Haas DA, Lennon D. A 21 year retrospective study of reports of paresthesia following local anesthetic administration. J Can Dent Assoc. 1995;61:319–330.
  15. Garisto GA, Gaffen AS, Lawrence HP, Tenenbaum HC, Haas DA. Occurrence of paresthesia after dental local anesthetic administration in the United States. J Am Dent Assoc. 2010;141:836–844.
  16. Hillerup S, Jensen RH, Ersboll BK. Trigeminal nerve injury associated with injection of local anesthetics: needle lesion or neurotoxicity. J Am Dent Assoc. 2011;142:531–539.
  17. Hillerup S, Bakke M, Larsen JO, Thomsen CE, Gerds TA. Concentration-dependent neurotoxicity of articaine: an electrophysiological and stereological study of the rat sciatic nerve. Anesth Analg. 2011;112:1330–1338.
  18. Morris R, McKay W, Mushlin P. Comparison of pain associated with intradermal and subcutaneous infiltration with various local anesthetic solutions. Anesth Analg. 1987;66:1180–1182.
  19. Wahl MJ, Overton D, Howell J, Siegel E, Schmitt MM, Muldoon M. Pain on injection of prilocaine plain vs. lidocaine with epinephrine. A prospective double-blind study. J Am Dent Assoc. 2001;132:1396–1401.
  20. Wahl MJ, Schmitt MM, Overton DA, Gordon MK. Injection pain of bupivacaine with epinephrine vs. prilocaine plain. J Am Dent Assoc. 2002;133:1652–1656.
  21. Yagiela JA. Local anesthetics. In: Dionne RA, Phero JP, Becker DE, editors. Management of Pain & Anxiety in the Dental Office. St Louis, Mo: WB Saunders/Elsevier Science; 2002.
  22. Brandt RG, Anderson PF, McDonald NJ, Sohn W, Peters MC. The pulpal anesthetic efficacy of articaine versus lidocaine in dentistry: a meta-analysis. J Am Dent Assoc. 2011;142:493–504.
  23. Malamed SF, Gagnon S, Leblanc D. Efficacy of articaine: a new amide local anesthetic. J Am Dent Assoc. 2000;131:635–642.
  24. Mikesell P, Nusstein J, Reader A, Beck M, Weaver J. A comparison of articaine and lidocaine for inferior alveolar nerve blocks. J Endod. 2005;31:265–270.
  25. Robertson D, Nusstein J, Reader A, Beck M, McCartney M. The anesthetic efficacy of articaine in buccal infiltration of mandibular posterior teeth. J Am Dent Assoc. 2007;138:1104–1112.
  26. Abdulwahab M, Boynes S, Moore P, et al. The efficacy of six local anesthetic formulations used for posterior mandibular buccal infiltration anesthesia. J Am Dent Assoc. 2009;140:1018–1024.
  27. Moore PA, Hersh EV, Papas AS, et al. Pharmacokinetics of lidocaine with epinephrine following local anesthesia reversal with phentolamine mesylate. Anesth Prog. 2008;55:40–48.
  28. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med. 1989;321:303–309.
  29. Dagher FB, Yared GM, Machtou P. An evaluation of 2% lidocaine with different concentrations of epinephrine for inferior alveolar nerve block. J Endod. 1997;23:178–180.
  30. Tofoli GR, Ramacciato JC, de Oliveira PC, et al. Comparison of effectiveness of 4% articaine associated with 1 ∶ 100,000 or 1 ∶ 200,000 epinephrine in inferior alveolar nerve block. Anesth Prog. 2003;50:164–168.
  31. Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill Companies Inc; 2011.
  32. Dionne RA, Goldstein DS, Wirdzek PR. Effects of diazepam premedication and epinephrine-containing local anesthetic on cardiovascular and catecholamine responses to oral surgery. Anesth Analg. 1984;63:640–646.
  33. Guglielmo A, Reader A, Nist R, Beck M, Weaver J. Anesthetic efficacy and heart rate effects of the supplemental intraosseous injection of 2% mepivacaine with 1 ∶ 20,000 levonordefrin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87:284–293.
  34. Lawaty I, Drum M, Reader A, Nusstein J. A prospective, randomized, double-blind comparison of 2% mepivacaine with 1 ∶ 20,000 levonordefrin versus 2% lidocaine with 1 ∶ 100,000 epinephrine for maxillary infiltrations. Anesth Prog. 2010;57:139–144.
  35. Becker DE. Adverse drug interactions. Anesth Prog. 2011;58:31–41.
  36. Foster CA. Aston SJ. Propranolol-epinephrine interaction: a potential disaster. Plast Reconstr Surg. 1983;72:74–78.
  37. Gandy W. Severe epinephrine-propranolol interaction. Ann Emerg Med. 1989;18:98–99.
  38. Mito RS, Yagiela JA. Hypertensive response to levonordefrin in a patient receiving propranolol: report of a case. J Am Dent Assoc. 1988;116:55–57.